NIH Director’s New Innovator Award Program (DP2)

Sponsor:National Institutes of Health
Learn More:NIH Director’s New Innovator Award Program (DP2)
Deadline:September 8, 2017, by 5:00 PM local time of applicant organization.
Award Max:Awards are multi-year funded, with all funds being disbursed in the first year of the award. Awards will be up to $1,500,000 in direct costs (the equivalent of $300,000 in Direct Costs each year for five years) plus applicable Facilities and Administrative (F&A) costs to be determined at the time of award.
Eligibility:Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. For the purpose of this FOA, multiple PD(s)/PI(s) are not allowed. Applicants must meet the definition of an Early Stage Investigator (ESI) at the time of application. An ESI is a new investigator (defined as a PD/PI who has not competed successfully for a significant NIH independent research award) who is within 10 years of completing his/her terminal research degree or is within 10 years of completing medical residency (or the equivalent). See the Office of Extramural Research for a complete list of NIH grants that do not disqualify a PD/PI as a new investigator and for frequently asked questions about the NIH Early Stage Investigator (ESI) Policy. An extension to the 10-year period may be granted under special circumstances (e.g., family care responsibilities, extended periods of clinical training, disability or illness, etc.). To request an extension, an applicant MUST complete the “Form for Requesting an Extension in the Early Stage Investigator (ESI) Period”. A request for extension must be approved at the time the NIH Director’s New Innovator Award application is submitted. It may take up to several weeks for the approval process, so applicants should plan accordingly. Applicants are responsible for reviewing and/or updating their degree information in their eRA Commons account in a timely fashion. Applicants should allow several weeks for an extension request to be processed. Note: If an applicant is not identified as an ESI in the eRA Commons, it may result in the application not being reviewed. Applicants also must hold an independent research position at a domestic (U.S.) institution as of September 1, 2018. For the purpose of this FOA, “independent research position” means a position that automatically confers eligibility, by the applicant’s institutional policy, for an investigator to apply for R01 grants, with an appropriate commitment of facilities to be used for the conduct of the proposed research. Investigators still in training or mentored status (postdoctoral fellows) are not eligible to apply unless they have a written commitment of an independent faculty position as of September 1, 2018, that is certified by submission of the application from that institution. Applicants may submit or have an R01 (or other equivalent) grant application pending concurrently with their NIH Director’s New Innovator Award application that does not overlap substantially with their New Innovator Award application. However, if that pending grant is awarded prior to the NIH Director’s New Innovator Award, then the applicant is no longer eligible to receive the New Innovator Award. Awardees are required to commit at least 25% of their research effort each year to activities supported by the New Innovator Award. For more details regarding eligibility requirements, see FAQs on the New Innovator website.
Abstract:

Supports a small number of early stage investigators of exceptional creativity who propose bold and highly innovative new research approaches that have the potential to produce a major impact on broad, important problems in biomedical and behavioral research. 

Category(s): social-science, health-science, life-science